Clinical and Pathological Response to Primary Chemotherapy in Operable Breast Cancer

By Chollet P.   Charrier S.   Brain E.   Cure H.   van Praagh I.   Feillel V.   de Latour M.   Dauplat J.   Misset J.-L.   Ferriere J.-P.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 862-866

Elsevier

Access to resources Recommend Favorite

ERBB2 overexpression in breast carcinomas - no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

By Vincent-Salomon A.   Carton M.   Freneaux P.   Palangie T.   Beuzeboc P.   Mouret E.   de Cremoux P.   Coue O.   Zafrani B.   Nicolas A.   Clough K.   Fourquet A.   Pouillart P.   Sastre-Garau X.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 586-591

Elsevier

Access to resources Recommend Favorite

Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 663-668

Spandidos Publications

Access to resources Recommend Favorite

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 83-89

Spandidos Publications

Access to resources Recommend Favorite